As of Aug 22
| +1.03 / +1.82%|
The 21 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 58.00, with a high estimate of 68.00 and a low estimate of 40.00. The median estimate represents a +0.57% increase from the last price of 57.67.
The current consensus among 24 polled investment analysts is to Buy stock in Bristol-Myers Squibb. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.